All Stories

  1. Molecular epidemiology of Tinea gladiatorum in contact sports in northern Iran
  2. Indole-derived chalcones as anti-dermatophyte agents: In vitro evaluation and in silico study
  3. Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans/Cryptococcus gattii species complex
  4. Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources
  5. In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis
  6. Discrimination of Aspergillus flavus from Aspergillus oryzae by matrix‐assisted laser desorption/ionization time‐of‐flight (MALDI‐TOF) mass‐spectrometry
  7. Trichophyton mentagrophytes and T interdigitale genotypes are associated with particular geographic areas and clinical manifestations
  8. Potential Fifth Clade ofCandida auris,Iran, 2018
  9. Identification of clinical dermatophyte isolates obtained from Iran by matrix-assisted laser desorption/ionization time-offlight mass spectrometry
  10. Novel Point Mutations in cyp51A and cyp51B Genes Associated with Itraconazole and Posaconazole Resistance in Aspergillus clavatus Isolates
  11. Fungal epidemiology in cystic fibrosis patients with a special focus on Scedosporium species complex
  12. Candida auris otomycosis in Iran and review of recent literature
  13. Niosome-loaded antifungal drugs as an effective nanocarrier system: A mini review
  14. Prevalence of specific immunoglobulin E and G against Aspergillus fumigatus in patients with asthma
  15. Prosthetic valve endocarditis caused by multidrug-resistant Candida albicans in a patient with myelodysplasia syndrome: A case report and literature review
  16. Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis
  17. In-vitro antifungal susceptibility testing of lanoconazole and luliconazole against Aspergillus flavus as an important agent of invasive aspergillosis
  18. Molecular identification and antifungal susceptibility testing of Candida species isolated from dental plaques
  19. Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies
  20. Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species
  21. In Vitro Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates
  22. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry
  23. Use of cell surface protein typing for genotyping of azole-resistant and -susceptible Aspergillus fumigatus isolates in Iran
  24. Invasive forms of Candida and Aspergillus in sputum samples of pulmonary tuberculosis patients attending the tuberculosis reference laboratory in Ghaemshahr, Northern Iran: An analysis of samples collected during the past 10years
  25. Characterization of clinically important dermatophytes in North of Iran using PCR-RFLP on ITS region
  26. Discrimination of Aspergillosis, Mucormycosis, Fusariosis, and Scedosporiosis in Formalin-Fixed Paraffin-Embedded Tissue Specimens by Use of Multiple Real-Time Quantitative PCR Assays
  27. Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus Strains
  28. In vitroactivity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates: Table 1.
  29. Staphylococcus aureus Enterotoxin B Down-Regulates the Expression of Transforming Growth Factor-Beta (TGF-β) Signaling Transducers in Human Glioblastoma
  30. Genetic and Morphological Diversity of the Genus Penicillium From Mazandaran and Tehran Provinces, Iran
  31. The First Case of Total Dystrophic Onychomycosis Caused by Aspergillus clavatus Resistant to Antifungal Drugs
  32. PCR-RFLP on β-tubulin gene for rapid identification of the most clinically important species of Aspergillus
  33. Dermatophytosis due to Microsporum incurvatum: Notification and Identification of a Neglected Pathogenic Species
  34. History of treated pulmonary tuberculosis will also be an underlying symptom of opportunistic aspergillosis by Aspergillus flavus: A case report
  35. Coexistence of opportunistic mycosis and mycobacterium tuberculosis in patients attending the Central Tuberculosis Reference Laboratory of Ghaemshahr city, Iran
  36. Restriction Analysis of β-Tubulin Gene for Differentiation of the Common Pathogenic Dermatophytes
  37. Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma
  38. Microsporum fulvum, an Ignored Pathogenic Dermatophyte: A New Clinical Isolation from Iran